this post was submitted on 15 Oct 2024
15 points (89.5% liked)

Futurology

1795 readers
60 users here now

founded 1 year ago
MODERATORS
top 7 comments
sorted by: hot top controversial new old
[–] TheTechnician27@lemmy.world 14 points 1 month ago* (last edited 1 month ago)

As opposed to a crappy content mill playing the telephone game.

[–] PennyRoyal@sh.itjust.works 7 points 1 month ago (2 children)

Is it speed? It’s speed, isn’t it?

[–] m4xie@lemmy.blahaj.zone 3 points 1 month ago

It's working great for me, but I definitely have ADHD

[–] MeowZedong@lemmygrad.ml 1 points 1 month ago

Looks like it's a monoclonal antibody design to decrease inflammation. The target is people with persistent, low levels of inflammation and major depression.

My institution doesn't give access, but my first question would be whether they accounted for treatment for the underlying cause of the inflammation. Persistent inflammation can cause all sorts of issues and I suppose a treatment for relief is good, but why does it exist? Treating the underlying condition seems more prudent unless they don't know the cause.

[–] wizardbeard@lemmy.dbzer0.com 0 points 1 month ago* (last edited 1 month ago) (2 children)

Is this not how most depression medicines work?

I thought that's why they all have warnings about increased thoughts of suicide, and why some doctors hesitate to prescribe: the meds might give someone in a bad place just enough of a push to get moving that they follow through with suicide.

[–] MeowZedong@lemmygrad.ml 2 points 1 month ago

No, not at all. This was looking at the effects of reducing inflammation on depression. Typical depression meds are meant to increase the availability of certain neurotransmitters such as serotonin.